首页> 外文会议>IEEE International Conference on Bioinformatics and Biomedicine >Bloodletting therapy combined with paroxetine hydrochloride for generalized anxiety disorder: A randomized controlled trial
【24h】

Bloodletting therapy combined with paroxetine hydrochloride for generalized anxiety disorder: A randomized controlled trial

机译:放血疗法联合盐酸帕罗西汀治疗广泛性焦虑症:一项随机对照试验

获取原文

摘要

This paper aims to verify the curative effect of Chinese bloodletting therapy combined with paroxetine hydrochloride for generalized anxiety disorder (GAD). A randomized controlled trial was conducted. 70 patients with GAD were randomly allocated to 2 groups. The experimental group received bloodletting therapy combined with paroxetine hydrochloride. The control group was given paroxetine hydrochloride alone. Each group received specific treatment for 4 weeks during the study. Outcome measures were Self-Rating Anxiety Scale (SAS) and effective rate. Measurements were taken before and after the study. Significant differences in SAS were found between the experimental group and control group after the treatment (P<0.05). The effective rate of experimental group was 82.4% and the control group was 52.9%. Bloodletting therapy combined with paroxetine hydrochloride is superior to using paroxetine hydrochloride alone for GAD.
机译:本文旨在验证中药放血疗法与盐酸帕罗西汀联合治疗对广泛性焦虑症(GAD)的疗效。进行了一项随机对照试验。将70名GAD患者随机分为2组。实验组接受放血疗法联合盐酸帕罗西汀。对照组仅给予帕罗西汀盐酸盐。在研究期间,每组接受为期4周的特定治疗。结果指标为自评焦虑量表(SAS)和有效率。在研究之前和之后进行测量。治疗后,实验组与对照组的SAS差异有统计学意义(P <0.05)。实验组有效率82.4%,对照组有效率52.9%。放血疗法与盐酸帕罗西汀联合使用优于单独使用盐酸帕罗西汀治疗GAD。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号